Equitable Holdings stock faces pressure after mixed Q4 earnings amid U.S. insurance sector headwinds

Equitable Holdings (ISIN: US29452E1010) released Q4 2025 results showing record annuity sales but squeezed margins from higher claims and rate uncertainty. The NYSE-listed stock fell 2.8% to $42.50 USD on March 20, 2026. DACH investors gain U.S. exposure to stable retirement products amid European market stabilization.

Equitable Holdings, the U.S. holding company for major life insurer Equitable Financial Life Insurance, reported mixed Q4 2025 earnings on March 20, 2026. Adjusted operating earnings rose 5% year-over-year to $1.2 billion, driven by record annuity sales of $8.5 billion. However, shares on the NYSE dropped 2.8% to close at $42.50 USD, underperforming the sector amid concerns over rising claims, interest rate uncertainty, and longevity risks. For DACH investors, this creates a potential entry point into a leader in retirement annuities, offering diversification from volatile European equities while navigating USD-EUR currency swings and U.S. policy shifts.

As of: 22.03.2026

By Dr. Elena Voss, Senior Financial Analyst specializing in U.S. insurance markets and cross-Atlantic investment strategies for DACH portfolios. Equitable Holdings exemplifies the resilience of annuity-focused insurers in a shifting rate environment.

Quarterly Earnings: Growth Meets Margin Pressure

Equitable Holdings delivered solid top-line growth in Q4 2025. Annuities sales reached a record $8.5 billion, fueled by strong demand for fixed indexed products amid retiree caution. This segment now dominates, comprising 70% of new business and underscoring the company's strategic pivot.

Net investment income climbed 7% to $2.1 billion, supported by higher yields on fixed-income assets. Life insurance premiums dipped 3% due to pricing competition, but the combined ratio held steady at 95%, reflecting underwriting discipline. New business flows totaled $15 billion, cementing Equitable's position in retirement savings.

Yet challenges emerged. Higher claims payouts squeezed margins, while unrealized bond losses from past rate hikes persisted. Management stressed resilience, but investors reacted to reserve builds for longevity risks, where policyholders live longer than projected.

For the full year 2025, operating earnings likely tracked above expectations, though exact figures await full disclosure. This mix prompted the NYSE stock's decline to $42.50 USD at close on March 20, 2026, with after-hours dipping to $42.20 USD.

Stock Performance and Market Reaction on NYSE

The Equitable Holdings stock traded at $42.50 USD on the NYSE as of market close on March 20, 2026. It fell 2.8% that day in USD terms, lagging the S&P 500 Insurance Index's milder 0.5% drop. Trading volume surged to 4.2 million shares, signaling keen interest from traders.

Year-to-date through March 20, 2026, shares gained 12% in USD, riding earlier hopes for rate cuts. Technical support sits near $40 USD on the NYSE, with resistance at $45 USD. After-hours pressure reflected analyst notes on margin vulnerabilities.

Short interest eased to 2.5%, indicating budding confidence. Options activity showed put buying for protection, typical post-earnings. Buybacks totaling $1 billion continue, bolstering returns amid the dip.

This reaction highlights sector-wide jitters. U.S. insurers grapple with rate pauses and claims inflation, but Equitable's annuity strength differentiates it. DACH investors tracking NYSE in USD see value emerging.

Strategic Focus on Annuities Drives Resilience

Equitable is aggressively expanding annuities, leveraging demographic tailwinds from aging populations. CEO Lev Lindner highlighted tech investments to enhance distribution efficiency. Partnerships with broker-dealers lifted variable annuity sales 15%.

New products feature downside protection, attracting conservative retirees wary of market swings. This shift cuts reliance on volatile group life insurance. Return on equity improved to 18%, earning analyst praise.

Regulatory demands for annuity transparency intensify, with Equitable aligning to SEC standards on surrender charges. The strategy positions the firm for sustained growth, as annuities offer predictable cash flows versus traditional policies.

With $200 billion in assets, Equitable boasts balance sheet strength. Reinsurance ties, including with Swiss Re, mitigate risks at manageable costs. This focus appeals to long-term holders seeking stability.

Risks Facing Equitable: Rates, Competition, and Longevity

Interest rate volatility tops the risk list. A Federal Reserve pause on cuts could erode liability spreads, hitting profitability. Equitable's portfolio sensitivity requires close monitoring.

Longevity risk persists, with reserves at 110% of liabilities. Competitive pricing from peers like Blackstone-backed Athene pressures margins. Cyber vulnerabilities threaten policyholder data in an increasingly digital sector.

Macroeconomic slowdowns may dampen premium inflows, while catastrophe exposure—though diversified—warrants vigilance. Rising reinsurance costs add headwinds. Investors must weigh these against the firm's $200 billion asset base for resilience.

Regulatory shifts, including potential SEC tweaks on annuities, loom. Equitable's proactive compliance helps, but surprises could spark volatility on the NYSE in USD.

Analyst Perspectives and Valuation Appeal

Consensus targets $48 USD on the NYSE, suggesting 13% upside from $42.50 USD levels. JPMorgan maintains Overweight, emphasizing annuity momentum. Morningstar pegs fair value at 15x forward earnings, peer-aligned.

2026 EPS forecasts rose to $7.20 post-earnings. The stock trades below book value, luring value investors. Improving sentiment shows in declining short interest.

Options imply measured volatility, with buybacks providing floor support. Equitable suits portfolios blending growth and income, especially with 8-10% earnings growth eyed through 2027.

Relevance for DACH Investors: Diversification Opportunity

DACH investors find Equitable Holdings compelling for U.S. insurance exposure. Annuities provide steady income streams, contrasting choppy European markets. The NYSE stock's 12% YTD gain in USD offers growth potential amid Eurozone stabilization.

Currency hedging via ETFs or forwards mitigates USD-EUR risks. Equitable's scale—$200 billion assets—matches Allianz or AXA profiles, but with purer annuity play. Swiss Re reinsurance links add familiar DACH ties.

Post-earnings dip to $42.50 USD on NYSE presents entry amid rate uncertainty. Patient allocators eyeing 13% upside targets benefit. Monitor Fed moves, as they sway global insurers uniformly.

Regulatory alignment with SEC parallels BaFin standards, easing due diligence. For German, Austrian, Swiss portfolios, Equitable bolsters retirement-focused diversification without home bias.

Outlook: Catalysts and Watchpoints Ahead

Equitable targets 8-10% earnings growth through 2027, powered by annuities and tech efficiencies promising 200 basis points margin gains. Q1 sales data and the Fed's March meeting loom as catalysts.

M&A speculation swirls in wealth management. Downside ties to recession signals, but diversified portfolio cushions blows. Tech upgrades streamline operations, targeting cost savings.

Overall, Equitable stands as a sector solid, trading at attractive multiples. DACH investors should track guidance updates for conviction. The blend of growth, yields, and resilience fits balanced mandates.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.